HER2 Expression in Gynecological Malignant Tumors in Chongqing Area of China

Clinical trial NCT06238284 · UNKNOWN

Trial details

NCT number: NCT06238284
Sponsor: Chongqing University Cancer Hospital
Status: UNKNOWN
Study type: OBSERVATIONAL

Cervical Cancer Endometrial Cancer Ovarian Cancer HER2 Expression

Start date: 2024-01-26
Primary completion: 2024-03-31
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.